Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update
about
NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?Implication of hepatokines in metabolic disorders and cardiovascular diseasesNAFLD and Chronic Kidney DiseaseGlycosyltransferases and non-alcoholic fatty liver diseaseOxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-AcetylcysteineNon-alcoholic fatty liver disease is not associated with a lower health perception.The role of lipids in the pathogenesis and treatment of type 2 diabetes and associated co-morbidities.Non-alcoholic fatty liver disease and diabetes.The Impact of Nonalcoholic Fatty Liver Disease on Renal Function in Children with Overweight/Obesity.Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling.Five gene variants in nonagenarians, centenarians and average individuals.Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.Vildagliptin: any effect on non-alcoholic fatty liver disease and serum uric acid? Re: Shelbaya S, Rakha S. Effectiveness and safety of vildagliptin and vildagliptin add-on to metformin in real-world settings in Egypt - results from the GUARD study.Cell adhesion molecule-1 (CADM1) shedding induces apoptosis of renal epithelial cells and exacerbates human nephropathies.Ipragliflozin and sodium glucose transporter 2 inhibitors to reduce liver fat: will the prize we sought be won?Non-invasive diagnosis of non-alcoholic fatty liver disease (NAFLD) using ultrasound image echogenicity.Dyslipidaemia in the elderly: to treat or not to treat?Biochemical Profile of Nonalcoholic Fatty Liver Disease Patients in Eastern India with Histopathological Correlation.Analogy between non-alcoholic steatohepatitis (NASH) and hypertension: a stepwise patient-tailored approach for NASH treatment.Current status of imaging in nonalcoholic fatty liver diseaseThe impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification
P2860
Q26750955-66943349-1AFE-40FB-841E-7B5D7E029782Q26751147-5AB9D66E-D923-4F43-A3D7-8306E44E8D84Q26752759-24EEF342-B4A7-49FA-8FBB-C5721B22F576Q26764913-A0ABCE01-7F42-42D1-B619-45C820F40F7EQ26773384-6703C364-2AE3-49E9-A586-7DE809030F66Q36859981-9267E787-35D0-43A3-8019-871EAC7C3758Q37024780-85FCFB1B-5F08-45DF-8FC1-BD645F9AA8C3Q37091659-436D17DD-2093-455D-8E7F-B2F28B388F7DQ37209898-808D93A2-6856-4A6C-A46E-C7EF0B51972EQ40176500-D4589270-B530-41FD-97A9-54DE57710B0DQ41549644-B5B49098-F936-4AE6-879F-16CDE618CBD3Q41549715-12B684BC-7DAE-45FB-B870-C0BBBBA173A0Q46357255-C0D0B859-64FC-4BBD-9C06-510F44C24A49Q47603508-6FE9A3C1-6A97-4FAB-A3E7-9F44616B0CEDQ48263840-E8080676-CCCD-4B70-9779-C6909FFE306CQ50071030-DF5E45F2-A74A-4008-A769-DC569E912EC2Q50180407-7E46CADC-114C-478D-8BDF-6DCD1246FA24Q51257432-F4680EC1-A7A1-4A6F-B3E5-C861DC14F88BQ55323878-B0D1DE54-B01A-4812-8F60-929B6A7ABB44Q58700636-D8A75BDF-67FA-4973-9AFF-E6CD071453C5Q58786857-5A9360EA-9410-4618-A285-1E57CCFE4D94
P2860
Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Cardiovascular risk across the ...... fatty liver disease: An update
@ast
Cardiovascular risk across the ...... fatty liver disease: An update
@en
Cardiovascular risk across the ...... fatty liver disease: An update
@nl
type
label
Cardiovascular risk across the ...... fatty liver disease: An update
@ast
Cardiovascular risk across the ...... fatty liver disease: An update
@en
Cardiovascular risk across the ...... fatty liver disease: An update
@nl
prefLabel
Cardiovascular risk across the ...... fatty liver disease: An update
@ast
Cardiovascular risk across the ...... fatty liver disease: An update
@en
Cardiovascular risk across the ...... fatty liver disease: An update
@nl
P2093
P2860
P3181
P356
P1476
Cardiovascular risk across the ...... fatty liver disease: An update
@en
P2093
Athyros VG
Karagiannis A
Mikhailidis DP
Tziomalos K
P2860
P304
P3181
P356
10.3748/WJG.V21.I22.6820
P407
P577
2015-06-14T00:00:00Z